Skip to content

XORTX
  • About
    • Management Team
    • Board of Directors
    • Advisory Board
  • Pipeline
    • Coronavirus – COVID-19 Program
    • Autosomal Dominant Polycystic Kidney Disease
    • Diabetic Nephropathy
  • Strategic Partnerships
  • Investors
    • Press Releases
    • Financials
    • SEDAR
    • Transfer Agent
    • Upcoming Events
  • Contact
Site Search

BIO CEO Investor Conference

BIO CEO Investor Conference

Press Releases

  • XORTX Therapeutics Strengthens Executive Team July 14, 2021
  • Dr. Stephen Haworth Joins XORTX Management Team June 30, 2021
  • XORTX Welcomes Jaqueline Le Saux to Board of Directors June 17, 2021
  • XORTX Welcomes New Member to Board of Directors May 13, 2021
  • XORTX Announces Notice to Grant European Patent April 6, 2021
XORTX Therapeutics Inc.
4000, 421 7th Avenue SW
Calgary, Alberta T2P 4K9
Ph: +1 (403) 455-7727
info@xortx.com
Theme by Colorlib Powered by WordPress